See our latest ARCHES analysis showing PSA nadir long term survival outcomes. ENZA/ADT durably beneficial even in those w/low PSA levels on initial ADT JAMA Network Open Arun Azad jamanetwork.com/journals/jaman… Duke Cancer DCI Center for Prostate & Urologic Cancers

💙First bladder transplant. Huge congratulations to Nima Nassiri, MD for his perseverance in making this dream a reality, and to #InderbirGill for once again advancing the field of urology. USC Urology UCLA Urology Amer. Urol. Assn. nytimes.com/2025/05/18/hea…

NEW: The EAU Guidelines Bot The right answers, seconds away Ask personalised treatment questions and receive instant answers based on the EAU Guidelines. Available in each topic section of the EAU Guidelines. Try it today via the Guidelines page: uroweb.org/guidelines

Nice slides to show comparison of ARPIs available. Do u use low dose Abiraterone with food ? I do. Also repeat after me ARPI dose not work after ARPI . OncoAlert Yakup Ergün Yüksel Ürün Oncology Brothers

Have you checked out the June Podcast? In the newest episode of the podcast Declan Murphy and Nikita Bhatt highlight two key papers from this month's journal, including interviews with key authors. They also catch up with Dr Eoin Dinneen (Melbourne, Australia), who gives a quick

🚨 NEW #PlatinumOpinion in European Urology by M. J. Roberts, Giorgio Gandaglia et al : 💡 Is extended pelvic lymph node dissection (ePLND) still justified in prostate cancer? 📉 No oncologic benefit in RCTs ⚠️ Up to 20% complication rate 🧬 PSMA PET reshapes staging 🔄 2024 EAU

The Inaugural GU Cast Journal Club is now live! With Carlos Delgado Elena K. Berg. Every month we select two key papers in GU Oncology, new or old, for a robust discussion #JournalClub Declan Murphy Renu Eapen youtu.be/A-jM8Z9GqhQ?si…

In a trial of men with suspected prostate cancer, biparametric MRI, which excludes the gadolinium contrast sequence, was noninferior to multiparametric MRI for detecting clinically significant cases. 🧵 ja.ma/4nhCVqy

At #ASTRO25 there are two entire sessions dedicated to #radiotherapy in kidney cancer! #kcsm. All-star🌟 cast, please pop by on Monday and/or Tuesday to learn something interesting about 🫘#radonc! ASTRO Kidney Cancer Peter Mac Radiation Oncology

Let’s Unite to Fight Cancer! 💪 Ten years ago, we made history with Australia’s first-ever Lutetium-PSMA treatment - research that’s changed prostate cancer care worldwide. Since then, our team has led 10+ clinical trials, bringing cutting-edge science straight to patients and

GU Cast Journal Club with Elena K. Berg Carlos Delgado Renu Eapen Declan Murphy. This month we critique the TRANSLATE trial and KEYNOTE-564. Tune in and get a great quick overview of two important trials! #prostatebiopsy #renalcancer #pembro youtu.be/E5uMaA1iQXk?si…

The bar is raised! Periop 🥪 EVP for cis ineligible (90%) or refusing (10%) MIBC = new SOC *KN905/EV302* ✅pT0 rate highest ever in MIBC 57% ITT, 65% cystectomy sub-pop ✅2yr EFS & OS on par w DDMVAC in cis eligible -cis eligible EVP🥪 trial *KNB15/EV304* readout awaited #ESMO25

📢 New SOC for MIBC #ESMO25 Dr. Christof Vulsteke presents KEYNOTE-905: 🚫 No cisplatin? No problem. EV+pembro delivers. 👥 n=344 cis-ineligible MIBC (80% renal impairment, 15% ECOG 2) 🔹 EFS HR 0.40 | OS HR 0.50 🔹 pCR: 57.1% vs 8.6% (ITT, non-op = non-responders) 🔹 No ↑

#ESMO25 ESMO - Eur. Oncology Too often, young people facing cancer still don’t receive proper #oncofertility counseling. This gap affects not only future fertility, but also quality of life and prognosis. Oncofertility is not optional but it’s part of comprehensive cancer care! OncoAlert

GU Cast Journal Club #2 - Elena K. Berg Carlos Delgado discuss TRANSLATE Trial & Keynote-564 with Renu Eapen Declan Murphy #SFVs here

Don’t miss out the latest GU cast Journal Club episode! Great discussion with Declan Murphy Renu Eapen Elena K. Berg GU Cast | Urology podcast! open.spotify.com/episode/1CCVN2…

At 23 years of follow-up, population-based PSA screening of asymptomatic men led to a sustained reduction in prostate cancer mortality, although overdiagnosis remains a concern. Full ERSPC study results: nej.md/42YYsg7 Editorial: Early Detection of Prostate Cancer —

Great study on an issue we face every day and may harm patients. Prostate cancer misinformation remains widespread on social media, shared by influencers and even colleagues. Let’s fight back with evidence-based content. Kudos to the authors!

GU Cast Journal Club #3 - Elena K. Berg Carlos Delgado discuss the classic ERSPC paper (perfect timing!) and NIAGARA with Renu Eapen Declan Murphy youtu.be/Gc-b5iHmsuE?si…